​

Corbus Pharmaceuticals Ownership | Who Owns Corbus Pharmaceuticals?

OverviewForecastRevenueFinancialsChart

Corbus Pharmaceuticals Ownership Summary

100.00% retail investors. SPDR® S&P Biotech ETF is the top mutual fund, with 3.12% of its assets in Corbus Pharmaceuticals shares.

CRBP Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCorbus Pharmaceuticals--100.00%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20231-98.41%100-100.00%-0.00%--100.00%1-93.75%
Dec 31, 2022635.00%11,889,537-49.17%92.72%2327.78%1614.29%
Sep 30, 202260-9.09%23,391,533-26.54%182.89%18-33.33%14-
Jun 30, 202266-8.33%31,842,077-15.02%252.84%273.85%14-36.36%
Mar 31, 202272-12.20%37,471,809-15.87%292.28%26-25.71%2210.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
SPDR® S&P Biotech ETF375.40K3.12%4.16K
Vanguard Total Stock Mkt Idx Inv362.22K2.97%33.00K
HBM Healthcare Investments AG Ord320.00K2.66%320.00K
iShares Russell 2000 ETF269.24K2.24%-602.00
Vanguard Institutional Extnd Mkt Idx Tr169.06K1.39%-
Global X Marijuana Life Sciences ETF163.50K1.34%-2.17K
Fidelity Small Cap Index104.06K0.86%-2.71K
Nuveen Quant Small Cap Equity R698.90K0.82%-
Fidelity Extended Market Index70.11K0.58%6.45K
State St Russell Sm/Mid Cp® Indx NL Cl C68.11K0.57%-2.10K

Recent Insider Transactions

DateNameRoleActivityValue
Sep 20, 2024Cormorant Asset Management, LP-Buy$1.02M
Sep 20, 2024Cormorant Asset Management, LP-Buy$2.85M
Sep 20, 2024Cormorant Asset Management, LP-Buy$1.30M
Sep 20, 2024Cormorant Asset Management, LP-Buy$476.31K
Sep 20, 2024Cormorant Asset Management, LP-Buy$572.79K

Insider Transactions Trends

DateBuySell
2024 Q2-7
2024 Q125-
2023 Q2--
2023 Q1--
2022 Q33-

CRBP Ownership FAQ

Who Owns Corbus Pharmaceuticals?

Corbus Pharmaceuticals shareholders are primarily institutional investors at 0.00%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Corbus Pharmaceuticals's industry, Biotech Stocks , is 47.04%, which Corbus Pharmaceuticals falls below.

Does Blackrock own Corbus Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Corbus Pharmaceuticals.

Who is the top mutual fund holder of Corbus Pharmaceuticals shares?

SPDR® S&P Biotech ETF is the top mutual fund holder of Corbus Pharmaceuticals shares, with 3.12% of its total shares outstanding invested in 375.4K Corbus Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools